Both behavioural and physiological factors have been proposed as mechanisms that may explain the negative effect of depression on coronary heart disease (CHD). Our aim is to review some of the most important findings since our prior review.
Method:
We searched MEDLINE, PsycINFO, and other sources for recent studies of candidate mechanisms, with an emphasis on publications since 2002.
Results:
Physiological pathways have received far greater attention than behavioural ones in the emerging literature. Recent studies have identified shared genetic determinants, inflammation, blood clotting, and vascular mechanisms as plausible explanatory mechanisms.
Conclusions:
Future research should focus on relations between behavioural and physiological mechanisms and on the effects of pharmacologic and psychotherapeutic treatments for depression on candidate mechanisms.
Frasure-SmithNLespéranceF.Recent evidence linking coronary heart disease and depression. Can J Psychiatry2006;51:730–7.
2.
CarneyRMFreedlandKEMillerGEJaffeAS. Depression as a risk factor for cardiac mortality and morbidity: A review of potential mechanisms. J Psychosom Res2002;53:897–902.
3.
CarneyRMFreedlandKESteinPKSkalaJAHoffmanPJaffeAS. Change in heart rate and heart rate variability during treatment for depression in patients with coronary heart disease. Psychosom Med2000;62:639–47.
4.
SerebruanyVLGlassmanAHMalininAINemeroffCBMusselmanDLvan ZylLT, and others. Sertraline AntiDepressant Heart Attack Randomized Trial Study Group. Platelet/endothelial biomarkers in depressed patients treated with the selective serotonin reuptake inhibitor sertraline after acute coronary events: The Sertraline AntiDepressant Heart Attack Randomized Trial (SADHART) Platelet Substudy. Circulation2003;108:939–44.
5.
RaoSVDonahueMPi-SunyerFXFusterV.Results of expert meetings: Obesity and cardiovascular disease. Obesity as a risk factor in coronary artery disease. Am Heart J2001;142:1102–7.
6.
Overweight, obesity, and health risk. National Task Force on the Prevention and Treatment of Obesity. Arch Intern Med2000;160:898–904.
7.
BrummettBHBabyakMASieglerICMarkDBWilliamsRBBarefootJC. Effect of smoking and sedentary behavior on the association between depressive symptoms and mortality from coronary heart disease. Am J Cardiol2003;92:529–32.
8.
EgedeLENietertPJZhengD.Depression and all-cause and coronary heart disease mortality among adults with and without diabetes. Diabetes Care2005;28:1339–45.
9.
RosengrenAHawkenSOunpuuSSliwaKZubaidMAlmahmeedWA, and others. Association of psychosocial risk factors with risk of acute myocardial infarction in 11 119 cases and 13 648 controls from 52 countries (the INTERHEART study): Case-control study. Lancet2004;364:953–62.
10.
DunlopDDLyonsJSManheimLMSongJChangRW. Arthritis and heart disease as risk factors for major depression: The role of functional limitation. Med Care2004;42:502–11.
11.
SurteesPGWainwrightNWKhawKTDayNE. Functional health status, chronic medical conditions and disorders of mood. Br J Psychiatry2003;183:299–303.
12.
GehiAHaasDPipkinSWhooleyMA. Depression and medication adherence in outpatients with coronary heart disease: Findings from the Heart and Soul Study. Arch Intern Med2005;165:2508–13.
13.
CarneyRMFreedlandKEEisenSARichMWJaffeAS. Major depression and medication adherence in elderly patients with coronary artery disease. Health Psychol1995;14:88–90.
14.
SkalaJAFreedlandKEEisenSACarneyRM. Depression, concentration, and medication adherence in patients with coronary artery disease. Ann Behav Med1994;16:S40.
15.
BundeJMartinR.Depression and prehospital delay in the context of myocardial infarction. Psychosom Med2006;68:51–7.
16.
CarneyRMFreedlandKEVeithRC. Depression, the autonomic nervous system, and coronary heart disease. Psychosom Med2005;67(suppl 1):S29–S33.
17.
KliksBRBurgessMJAbildskovJA. Influence of sympathetic tone on ventricular fibrillation threshold during experimental coronary occlusion. Am J Cardiol1975;36:45–9.
18.
PodridPJFuchsTCandinasR.Role of the sympathetic nervous system in the genesis of ventricular arrhythmia. Circulation1990;82:I103–I113.
19.
SchwartzPJVanoliE.Cardiac arrhythmias elicited by interaction between acute myocardial ischemia and sympathetic hyperactivity: A new experimental model for the study of antiarrhythmic drugs. J Cardiovasc Pharmacol1981;3:1251–9.
20.
Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart rate variability: Standards of measurement, physiological interpretation and clinical use. Circulation1996;93:1043–65.
21.
BiggerJTJr.FleissJLSteinmanRCRolnitzkyLMKleigerRERottmanJN. Frequency domain measures of heart period variability and mortality after myocardial infarction. Circulation1992;85:164–71.
22.
KleigerREMillerJPBiggerJTJrMossAJ. Decreased heart rate variability and its association with increased mortality after acute myocardial infarction. Am J Cardiol1987;59:256–62.
23.
RichMWSainiJSKleigerRECarneyRMteVeldeAFreedlandKE. Correlation of heart rate variability with clinical and angiographic variables and late mortality after coronary angiography. Am J Cardiol1988;62:714–7.
24.
VaishnavSStevensonRMarchantBLagiKRanjadayalanKTimmisAD. Relation between heart rate variability early after acute myocardial infarction and long-term mortality. Am J Cardiol1994;73:653–7.
25.
CarneyRMRichMWteVeldeASainiJClarkKFreedlandKE. The relationship between heart rate, heart rate variability and depression in patients with coronary artery disease. J Psychosom Res1988;32:159–64.
26.
CarneyRMSaundersRDFreedlandKESteinPRichMWJaffeAS. Association of depression with reduced heart rate variability in coronary artery disease. Am J Cardiol1995;76:562–4.
27.
CarneyRMBlumenthalJASteinPKWatkinsLCatellierDFreedlandKE, and others. Depression, heart rate variability, and acute myocardial infarction. Circulation2001;104:2024–8.
28.
GuinjoanSMde GuevaraMSCorreaCSchauffeleSINicola-SiriLFahrerRD, and others. Cardiac parasympathetic dysfunction related to depression in older adults with acute coronary syndromes. J Psychosom Res2004;56:83–8.
29.
KrittayaphongRCascioWELightKCSheffieldDGoldenRNShepsDS, and others. Heart rate variability in patients with coronary artery disease: Differences in patients with higher and lower depression scores. Psychosom Med1997;59:231–5.
30.
SteinPKCarneyRMFreedlandKESkalaJAJaffeASKleigerRE, and others. Severe depression is associated with markedly reduced heart rate variability in patients with stable coronary heart disease. J Psychosom Res2000;48:493–500.
31.
GehiAManganoDPipkinSBrownerWSWhooleyMA. Depression and heart rate variability in patients with stable coronary heart disease: Findings from the Heart and Soul Study. Arch Gen Psychiatry2005;62:661–6.
32.
OtteCNeylanTCPipkinSSBrownerWSWhooleyMA. Depressive symptoms and 24-hour urinary norepinephrine excretion levels in patients with coronary disease: Findings from the Heart and Soul Study. Am J Psychiatry2005;162:2139–45.
33.
CarneyRMFreedlandKEVeithRCCryerPESkalaJAJaffeAS, and others. Major depression, heart rate, and plasma norepinephrine in patients with coronary heart disease. Biol Psychiatry1999;45:458–63.
34.
CarneyRMHowellsWBBlumenthalJAFreedlandKESteinPKJaffeAS, and others. Heart rate turbulence, depression, and survival after acute myocardial infarction. Psychosom Med 2006. Psychosom Med2006;68:443–8.
35.
CarneyRMFreedlandKESteinPKWatkinsLLJaffeASYeraganiVK, and others. Effects of depression on QT interval variability after myocardial infarction. Psychosom Med2003;62:177–80.
36.
CarneyRMBlumenthalJAFreedlandKESteinPKWatkinsLLJaffeAS, and others. Low heart rate variability and the effect of depression on post-myocardial infarction mortality. Arch Intern Med2005;165:1486–91.
37.
SelwynAP. Prothrombotic and antithrombotic pathways in acute coronary syndromes. Am J Cardiol2003;91:3H–11H.
38.
CarneyRMFreedlandKE. Depression, mortality, and medical morbidity in patients with coronary heart disease. Biol Psychiatry2003;54:241–7.
39.
CascioWE. Myocardial ischemia: What factors determine arrhythmogenesis?J Cardiovasc Electrophysiol2001;12:726–9.
40.
GhuranAVCammAJ. Ischaemic heart disease presenting as arrhythmias. Br Med Bull2001;59:193–210.
41.
SerebruanyVLGlassmanAHMalininAISaneDCFinkelMSKrishnanRR, and others. Enhanced platelet/endothelial activation in depressed patients with acute coronary syndromes: Evidence from recent clinical trials. Blood Coagul Fibrinolysis2003;14:563–7.
42.
von KanelR.Platelet hyperactivity in clinical depression and the beneficial effect of antidepressant drug treatment: How strong is the evidence?Acta Psychiatr Scand2004;110:163–77.
43.
BroadleyAJKorszunAJonesCJFrenneauxMP. Arterial endothelial function is impaired in treated depression. Heart2002;88:521–3.
44.
RajagopalanSBrookRRubenfireMPittEYoungEPittB.Abnormal brachial artery flow-mediated vasodilation in young adults with major depression. Am J Cardiol2001;88:196–8, A7.
45.
SherwoodAHinderliterALWatkinsLLWaughRABlumenthalJA. Impaired endothelial function in coronary heart disease patients with depressive symptomatology. J Am Coll Cardiol2005;46:656–9.
46.
MillerGEStetlerCACarneyRMFreedlandKEBanksWA. Clinical depression and inflammatory risk markers for coronary heart disease. Am J Cardiol2002;90:1279–83.
47.
MillerGEFreedlandKECarneyRMStetlerCABanksWA. Cynical hostility, depressive symptoms, and the expression of inflammatory risk markers for coronary heart disease. J Behav Med2003;26:501–15.
48.
DannerMKaslSVAbramsonJLVaccarinoV.Association between depression and elevated C-reactive protein. Psychosom Med2003;65:347–56.
49.
EmpanaJPSykesDHLucGJuhan-VagueIArveilerDFerrieresJ, and others of the PRIME Study Group. Contributions of depressive mood and circulating inflammatory markers to coronary heart disease in healthy European men: The Prospective Epidemiological Study of Myocardial Infarction (PRIME). Circulation2005;111:2299–305.
50.
LesperanceFFrasure-SmithNTherouxPIrwinM.The association between major depression and levels of soluble intercellular adhesion molecule 1, interleukin-6, and C-reactive protein in patients with recent acute coronary syndromes. Am J Psychiatry2004;161:271–7.
51.
MillerGEFreedlandKEDuntleySCarneyRM. Relation of depressive symptoms to C-reactive protein and pathogen burden (cytomegalovirus, herpes simplex virus, Epstein-Barr virus) in patients with earlier acute coronary syndromes. Am J Cardiol2005;95:317–21.
52.
SchinsATulnerDLousbergRKenisGDelangheJCrijnsHJ, and others. Inflammatory markers in depressed post-myocardial infarction patients. J Psychiatr Res2005;39:137–44.
53.
HjerkinnEMSeljeflotIEllingsenIBerstadPHjermannISandvikL, and others. Influence of long-term intervention with dietary counseling, long-chain n-3 fatty acid supplements, or both on circulating markers of endothelial activation in men with long-standing hyperlipidemia. Am J Clin Nutr2005;81:583–9.
54.
PischonTHankinsonSEHotamisligilGSRifaiNWillettWCRimmEB. Habitual dietary intake of n-3 and n-6 fatty acids in relation to inflammatory markers among US men and women. Circulation2003;108:155–60.
55.
RosENunezIPerez-HerasASerraMGilabertRCasalsEDeulofeuR.A walnut diet improves endothelial function in hypercholesterolemic subjects: A randomized crossover trial. Circulation2004;109:1609–14.
56.
Kris-EthertonPMHarrisWSAppelLJ, American Heart Association Nutrition Committee. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation2002;106:2747–57.
57.
AlbertCMCamposHStampferMJRidkerPMMansonJEWillettWCMaJ.Blood levels of long-chain n-3 fatty acids and the risk of sudden death. New Engl J Med2002;346:1113–8.
58.
BrouwerIAZockPLvan AmelsvoortLGKatanMBSchoutenEG. Association between n-3 fatty acid status in blood and electrocardiographic predictors of arrhythmia risk in healthy volunteers. Am J Cardiol2002;89:629–31.
59.
TanskanenAHibbelnJRHintikkaJHaatainenKHonkalampiKViinamakiH.Fish consumption, depression, and suicidality in a general population. Arch Gen Psychiatry2001;58:512–3.
60.
HibbelnJR. Fish consumption and major depression. Lancet1998;351:1213.
61.
AdamsPBLawsonSSanigorskiASinclairAJ. Arachidonic acid to eicosapentaenoic acid ratio in blood correlates positively with clinical symptoms of depression. Lipids1996;31:S157–S161.
62.
PeetMHorrobinDF. A dose-ranging study of the effects of ethyl-eicosapentaenoate in patients with ongoing depression despite apparently adequate treatment with standard drugs. Arch Gen Psychiatry2002;59:913–9.
63.
NemetsBStahlZBelmakerRH. Addition of omega-3 fatty acid to maintenance medication treatment for recurrent unipolar depressive disorder. Am J Psychiatry2002;159:477–9.
64.
StollALLockeCAMarangellLBSeverusWE. Omega-3 fatty acids and bipolar disorder: A review. Prostaglandins Leukot Essent Fatty Acids1999;60:329–37.
65.
Frasure-SmithNLesperanceFJulienP.Major depression is associated with lower omega-3 fatty acid levels in patients with recent acute coronary syndromes. Biol Psychiatry2004;55:891–6.
66.
KendlerKSNealeMCKesslerRCHeathACEavesLJ. A population-based twin study of major depression in women. The impact of varying definitions of illness. Arch Gen Psychiatry1992;49:257–66.
67.
LyonsMJEisenSAGoldbergJTrueWLinNMeyerJM, and others. A registry-based twin study of depression in men. Arch Gen Psychiatry1998;55:468–72.
68.
AustinMAKingMCBawolRDHulleySBFriedmanGD. Risk factors for coronary heart disease in adult female twins. Genetic heritability and shared environmental influences. Am J Epidemiol1987;125:308–18.
69.
FeinleibMGarrisonRJFabsitzRChristianJCHrubecZBorhaniNO, and others. The NHLBI twin study of cardiovascular disease risk factors: Methodology and summary of results. Am J Epidemiol1977;106:284–5.
70.
FriedlanderYSiscovickDSWeinmannSAustinMAPsatyBMLemaitreRN, and others. Family history as a risk factor for primary cardiac arrest. Circulation1998;97:155–60.
71.
ReedTQuirogaJSelbyJVCarmelliDChristianJCFabsitzRR, and others. Concordance of ischemic heart disease in the NHLBI twin study after 14–18 years of follow-up. J Clin Epidemiol1991;44:797–805.
72.
ScherrerJFXianHBucholzKKEisenSALyonsMJGoldbergJ, and others. A twin study of depression symptoms, hypertension, and heart disease in middle-aged men. Psychosom Med2003;65:548–57.
73.
LicinioJYildizBWongML. Depression and cardiovascular disease: Co-occurrence or shared genetic substrates?Mol Psychiatry2002;7:1031–2.
74.
de GeusEJ. Genetic pleiotropy in depression and coronary artery disease. Psychosom Med2006;68:185–6.
75.
NakataniDSatoHSakataYShiotaniIKinjoKMizunoH, and others. Influence of serotonin transporter gene polymorphism on depressive symptoms and new cardiac events after acute myocardial infarction. Am Heart J2005;150:652–8.
76.
McCafferyJMFrasure-SmithNDubeMPTherouxPRouleauGADuanQLesperanceF.Common genetic vulnerability to depressive symptoms and coronary artery disease: A review and development of candidate genes related to inflammation and serotonin. Psychosom Med2006;68:187–200.
